Criteria for referring patients with renal disease for nephrology consultation: a review of the literature.
نویسندگان
چکیده
INTRODUCTION Referrals to nephrologists comprise not only patients with chronic kidney disease but also those with other nephrological conditions. There may be confusion about when to refer a patient to a nephrologist. We conducted a literature review to identify preexisting priority-setting, triage or referral criteria developed to guide referrals from primary care to a nephrologist. METHODS Medline and Cochrane databases were searched (1997 to 2008) using search terms: referral, consultation, triage and a list of specified nephrological conditions. Abstracts were assessed by 2 reviewers using criteria to determine relevance. Citation and hand searches were done on papers selected for review; relevant Web sites were also consulted. Two reviewers read all selected papers to determine if they met the objectives. One reviewer abstracted relevant data from each retained reference and compiled the results into a report, which was reviewed by 3 practicing nephrologists. RESULTS There were 18 retained papers, reports or Web sites; 4 of these were professional national guidelines. All but 1 reference cited serum creatinine or estimated glomerular filtration rate as a criterion for referral. Other referral criteria were proteinuria (8 sources), blood pressure (5 sources), electrolytes (3 sources) or hematuria (3 sources). There was inconsistency in referral recommendations. CONCLUSIONS The differing advice identified in the literature results in confusion as to when patients should be referred to a nephrologist. Nephrologists, an already strained human resource, must prioritize requests for consultation using an undefined and no doubt inconsistent metric. Standardized, diagnosis-neutral criteria would benefit both primary care providers and nephrologists.
منابع مشابه
Kidney Transplantation in Iran
Kidney transplantation in patients with end stage renal disease is preferred to dialysis because transplantation provides a better quality of life andimproved survival. However, the gap between the supply and demand for a renal allograft is widening and the waiting time is increasing. Iranian protocol, a controlled transplant program supported by the government for living unrelated donors, was ...
متن کاملPrevalence and Causes of Chronic Kidney Disease in Patients Referred to the Nephrology Clinic in Ilam
Introduction: The prevalence of chronic kidney disease (CKD) is increasing in developed and developing countries, such as Iran. This disorder affects all economic, social, and psychological aspects of the patient’s life. The first step in preventing the spread of a disease is to know the prevalence and causes of the disease. This study aimed to determine the prevalence of CKD and its causes in ...
متن کاملALUMINUM TOXICITY: A REVIEW IN RELATION TO CHRONIC RENAL FAILURE PATIENTS M AINTAINED ON REGULAR HEMODIALYSIS
Aluminum is present in very small amounts in living organisms but abundant in the environment. A growing literature links with the biochemistry of aluminum and also with a series of diseases in chronic renal failure patients on treatment with hemodialysis. The initial description of potential aluminum toxicity in renal failure patients relates to description of dialysis encephalopathy syndr...
متن کاملLiterature review in the treatment of calciphylaxis:A case with uncontrolled and severe secondary hyperparathyroidism
Background: Calciphylaxis is a serious disorder often observed in dialysis patients and less frequently in chronic renal failure patients with secondary hyperparathyroidism. Mortality rate increases following the development of calciphylaxis, immediate application of parathyroidectomy along with other treatment options may be lifesaving. Case Presentation: A 44-year-old male patient had been...
متن کاملHemoglobin And Hematocrit Rise In End-Stage Renal Disease (ESRD) With PDpoetin: Results Of A Phase Ш, Multicenter Clinical Trial
Background and Objective: The anemia of ESRD is a complex disorder, associated with serious complications, which increases patients’ mortality and morbidity. Treatment of this anemia with recombinant human erythropoietin (rh-EPO) is well established. This clinical trial study was conducted within 20 months, from May 2005 to December 2006, in order to evaluate the efficacy of PDpoetin (rh-EPO...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Journal of nephrology
دوره 23 4 شماره
صفحات -
تاریخ انتشار 2010